Literature DB >> 21598112

Methylated promoters of genes encoding protocadherins as a new cancer biomarker family.

Xinbing Sui1, Da Wang, Shumin Geng, Gongli Zhou, Chao He, Xiaotong Hu.   

Abstract

Protocadherins are a major subfamily of the cadherin superfamily. Their functions and intracellular signal transduction are poorly understood, although some have been explored in nervous system development. However, recent researches have shown that protocadherins frequently act as tumor suppressor genes (TSGs) and inactivation of these genes through promoter methylation is closely correlated with tumor development. Furthermore, these methylated protocadherins may serve as tumor biomarkers in various body fluids, stool and scrapings not only for early cancer diagnosis, but also for assessing prognosis and monitoring response to therapy. Thus, methylated promoters of genes encoding protocadherins show promise as a new cancer biomarker family.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598112     DOI: 10.1007/s11033-011-0837-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  62 in total

Review 1.  Molecular evolution of the cadherin superfamily.

Authors:  Paco Hulpiau; Frans van Roy
Journal:  Int J Biochem Cell Biol       Date:  2008-10-04       Impact factor: 5.085

2.  Identification of long-range regulatory elements in the protocadherin-alpha gene cluster.

Authors:  Scott Ribich; Bosiljka Tasic; Tom Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

3.  Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.

Authors:  M R Morris; C J Ricketts; D Gentle; F McRonald; N Carli; H Khalili; M Brown; T Kishida; M Yao; R E Banks; N Clarke; F Latif; E R Maher
Journal:  Oncogene       Date:  2010-12-06       Impact factor: 9.867

4.  Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma.

Authors:  Melissa de Freitas Cordeiro-Silva; Zilda Fagundes Lima Oliveira; José Roberto Vasconcelos de Podestá; Sonia Alves Gouvea; Sandra Ventorin Von Zeidler; Iúri Drumond Louro
Journal:  Mol Biol Rep       Date:  2011-03-05       Impact factor: 2.316

5.  Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease.

Authors:  Fabian Model; Neal Osborn; David Ahlquist; Robert Gruetzmann; Bela Molnar; Ferenc Sipos; Orsolya Galamb; Christian Pilarsky; Hans-Detlev Saeger; Zsolt Tulassay; Kari Hale; Suzanne Mooney; Joseph Lograsso; Peter Adorjan; Ralf Lesche; Andreas Dessauer; Joerg Kleiber; Baerbel Porstmann; Andrew Sledziewski; Catherine Lofton-Day
Journal:  Mol Cancer Res       Date:  2007-02       Impact factor: 5.852

6.  Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells.

Authors:  S Parenti; F Ferrarini; R Zini; M Montanari; L Losi; B Canovi; S Ferrari; A Grande
Journal:  Aliment Pharmacol Ther       Date:  2010-01       Impact factor: 8.171

7.  Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation.

Authors:  Noriko Okazaki; Naomi Takahashi; Shin-Ichi Kojima; Yasuhiko Masuho; Hisashi Koga
Journal:  Carcinogenesis       Date:  2002-07       Impact factor: 4.944

8.  Cadherin-11 controls otolith assembly: evidence for extracellular cadherin activity.

Authors:  Sherry G Clendenon; Bijal Shah; Caroline A Miller; Glen Schmeisser; Amanda Walter; Vincent H Gattone; Kate F Barald; Qin Liu; James A Marrs
Journal:  Dev Dyn       Date:  2009-08       Impact factor: 3.780

9.  Elephant shark sequence reveals unique insights into the evolutionary history of vertebrate genes: A comparative analysis of the protocadherin cluster.

Authors:  Wei-Ping Yu; Vikneswari Rajasegaran; Kenneth Yew; Wai-Lin Loh; Boon-Hui Tay; Chris T Amemiya; Sydney Brenner; Byrappa Venkatesh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-04       Impact factor: 11.205

10.  Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations.

Authors:  Elin Org; Susana Eyheramendy; Peeter Juhanson; Christian Gieger; Peter Lichtner; Norman Klopp; Gudrun Veldre; Angela Döring; Margus Viigimaa; Siim Sõber; Kärt Tomberg; Gertrud Eckstein; Piret Kelgo; Tiina Rebane; Sue Shaw-Hawkins; Philip Howard; Abiodun Onipinla; Richard J Dobson; Stephen J Newhouse; Morris Brown; Anna Dominiczak; John Connell; Nilesh Samani; Martin Farrall; Mark J Caulfield; Patricia B Munroe; Thomas Illig; H-Erich Wichmann; Thomas Meitinger; Maris Laan
Journal:  Hum Mol Genet       Date:  2009-03-20       Impact factor: 6.150

View more
  7 in total

1.  COP1 Acts as a Ubiquitin Ligase for PCDH9 Ubiquitination and Degradation in Human Glioma.

Authors:  Kunlin Zhou; Lei Wang; Zhiyuan Sun; Yuelin Liu; Yufu Zhu; Zhiyi Liu; Bin Zhang; Hengliang Shi
Journal:  Mol Neurobiol       Date:  2022-01-27       Impact factor: 5.590

2.  Effects on specific promoter DNA methylation in zebrafish embryos and larvae following benzo[a]pyrene exposure.

Authors:  J Corrales; X Fang; C Thornton; W Mei; W B Barbazuk; M Duke; B E Scheffler; K L Willett
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2014-02-24       Impact factor: 3.228

3.  Epigenetic-Mediated Downregulation of μ-Protocadherin in Colorectal Tumours.

Authors:  Mateusz Bujko; Paulina Kober; Małgorzata Statkiewicz; Michal Mikula; Marcin Ligaj; Lech Zwierzchowski; Jerzy Ostrowski; Janusz Aleksander Siedlecki
Journal:  Gastroenterol Res Pract       Date:  2015-04-20       Impact factor: 2.260

4.  Hypermethylation of protocadherin γ subfamily A12 and solute carrier family 19 A 1 promoters contributes to the occurrence and metastasis of colorectal cancer.

Authors:  Cheng Zhang; Jinyun Li; Tao Huang; Cheng Chen; Qingxiao Hong; Huihui Ji; Meng Ye; Shiwei Duan
Journal:  Oncol Lett       Date:  2018-03-30       Impact factor: 2.967

5.  MiR-200a-3p promoted the malignant behaviors of ovarian cancer cells through regulating PCDH9.

Authors:  Can Shi; Yijun Yang; Lei Zhang; Juanpeng Yu; Shanshan Qin; Hongge Xu; Yingchun Gao
Journal:  Onco Targets Ther       Date:  2019-10-08       Impact factor: 4.147

6.  Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma.

Authors:  Ya He; Zhihai Wang; Chuan Liu; Zhitao Gong; Yanshi Li; Tao Lu; Guohua Hu
Journal:  Cancer Manag Res       Date:  2019-02-18       Impact factor: 3.989

7.  The role of epigenetic modifications, long-range contacts, enhancers and topologically associating domains in the regulation of glioma grade-specific genes.

Authors:  Ilona E Grabowicz; Bartek Wilczyński; Bożena Kamińska; Adria-Jaume Roura; Bartosz Wojtaś; Michał J Dąbrowski
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.